Product
Cilofexor
Aliases
GS-9674
2 clinical trials
2 indications
Indication
Primary Sclerosing CholangitisIndication
CirrhosisClinical trial
A Proof-of-Concept, Open-Label Study Evaluating the Safety and Tolerability of Cilofexor in Subjects With Primary Sclerosing Cholangitis (PSC) and Compensated CirrhosisStatus: Terminated, Estimated PCD: 2021-09-02
Clinical trial
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of Cilofexor in Non-Cirrhotic Subjects With Primary Sclerosing CholangitisStatus: Terminated, Estimated PCD: 2022-11-10